Overview
EPRX market data
Price History
EPRX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.97 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.20 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $6.72 – $12.86 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $594.5 · P/B 4.56.
Company news
Oppenheimer Initiates Coverage On Eupraxia Pharmaceuticals with Outperform Rating, Announces Price Target of $17Benzinga · Jun 26, 2026, 1:20 PM
Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of ShareholdersGlobenewswire Inc · Jun 19, 2026, 9:15 PM
VNET Group, Akari Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionBenzinga · May 26, 2026, 12:06 PM
Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving PremarketBenzinga · May 26, 2026, 10:00 AM
This SailPoint Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For ThursdayBenzinga · May 21, 2026, 1:50 PM
Eupraxia Pharmaceuticals Q1 EPS $(0.23) Misses $(0.22) EstimateBenzinga · May 12, 2026, 9:10 PM